MiNK Therapeutics, Inc. is a biopharmaceutical company. The Company is specialized in discovery, development and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediate... Read more
MarketWatch
CNBC
Yahoo
CNBC
Access detailed stock analysis from LSEG including analyst price target estimates.